Studies showed that the polymorphisms of FGFR1 are related to HBV-related HCC, but they do not have an independent role in tumorigenesis and progression (Wang et al., 2013; Xie et al., 2015). This evidence concerns the gene FGFR1 and hepatocellular carcinoma.